A simple UV spectrophotometric method for the determination of levofloxacin in dosage formulations

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 1, 2011, Pages 75-79

  Desai, V N ^a   Afieroho, Ozadheoghene E ^b   Dagunduro, B O ^a   Okonkwo, T J ^c   Ndu, C C ^a  

^a Research and Development Laboratories   (Nigeria)

^b NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

^c UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

Dosage formulations; Levofloxacin; Quality control; Spectrophotometric method; Validation

Indexed keywords

EXCIPIENT; LEVOFLOXACIN;

ACCURACY; ARTICLE; CALIBRATION; CONCENTRATION PROCESS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG LABELING; DRUG MARKETING; NIGERIA; PROCESS DEVELOPMENT; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 79951789580     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v10i1.66545     Document Type: Article

References (12)

1. Gomes GC, Salgado HRN. Validation of UV Spectrophotometric method for determination of Lomefloxacin in Pharmaceutical Dosage Form. Acta Farm. Bonaerense, 2005; 24 (3): 406-408
2. El-Brashy AM, Metwally ME, El-Sepai FA. Spectrophotometric determination of Some Fluoroquinolone Antibacterials through Charge-transfer and Ion-pair Complexation Reactions. Bull. Korean Chem. Soc., 2004; 25 (3): 365-372
3. Ross DL, Riley CM. Antibacterial effect of nalidixic acid derivatives. Intl. J.Pharm., 1990; 63: 237-240.
4. Macor JE. Annual Report in Medicinal Chemistry, Vol 21. London: Academic Press, 2007; p 331
5. United States Pharmacopoeia XXIV /National Formulary 19, US Pharmacopeial Convention, Rockville, M.D, 2000
6. The British Pharmacopoeia. London: Her Majesty's Stationery Office, 1998.
7. The United States Pharmacopoiea Convention. Pending monograph guideline, Version 2, 2009. [Acessed 9 March 2010] Available from: http://www.usp.org
8. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use: Harmonised Triplicate Guideline on Validation of Analytical Procedures: Methodology, Recommended for Adoption at Step 4 of the ICH Process by the ICH Steering Committee, IFPMA, Switzerland.1996.
9. Bandarkar FS, Vavia PR. A Stability Indicating HPLC Method for the Determination of Meloxicam in Bulk and Commercial Formulations Trop J Pharm Res, 2009; 8 (3): 257-264
10. Guidance for Industry Bioanalytical Method Validation. US Department of Health and Human Services, May 2001.
11. Liu P, Liang S, Wang B, Guo R. Development and validation of a sensitive LC-MS method for the determination of promethazine hydrochloride in human plasma and urine. Eur. J. Drug Metab. Pharmacokinet., 2009; 34 (3&4): 177-184.
12. Rahman N, Ahmad Y, Azmi SNH. Kinetic Spectrophotometric Method for the determination of Ramipril in Pharmaceutical Formulations. AAPS Pharm Sci Tech. 2005; 6(3): E543-E551.